Posted by Michael Wonder on 21 Dec 2022
Classifying ageing as a disease could speed FDA drug approvals
21 December 2022 - The FDA considers ageing to be a natural process. This makes it difficult to get FDA approval for drugs that seek to slow or reverse the biological process of ageing.
Instead, drugs intended to target ageing must target a disease that often results from the ageing process in order to demonstrate efficacy and gain approval.
